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Abstract
Sarcomas of the testis are extremely rare tumors, their incidence being difficult
to assess accurately. The authors report a case of a 21-year-old male, presented
with painless scrotal swelling that increased in size insidiously within three months.
The examination revealed a 10 cm right testicular swelling—hard, not tender and
oval in shape. Testicular ultrasound revealed right heterogenous testicular mass.
Tumor markers (Human chorionic gonadotrophin (HCG) and alpha fetoprotein) were
normal. CT chest and abdomenwere normal. Radical orchidectomywas done through
an inguinal approach. Histopathology showed testicular fibrosarcoma with spindle
cells. After one month, the patient noticed reappearance of a swelling in the right
hemiscrotum. Right inguinal exploration with massive resection of the recurrent
scrotal mass was done. Histopathology revealed inflammatory process dominated
by stitch granuloma. In conclusion, the recurrence rate of testicular sarcomas is high
following radical orchidectomy, but still there was a place of non-malignant mass
that looks like recurrence; it might occur like nonspecific inflammatory mass and stich
granuloma.
Keywords: testicular tumor, testicular fibrosarcoma, spindle cells, recurrent testicular
sarcoma
1. Introduction
Testicular cancer represents about 1.5% of male neoplasms and 5% genitourinary
tumors. Most testicular tumors are diagnosed in 20th and 30th years of life. The his-
tological type varies, although there is a clear predominance (90–95%) of germ cell
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tumors [1]. Testicular sarcomas are extremely rare tumors, their incidence being diffi-
cult to assess accurately. Although uncommon, these tumors have been recorded as
themain urogenital site of sarcomas in the elderly, whereas primary testicular sarcoma
is rare neoplasm, in which the diagnosis is made after exclusion of the more common
type of sarcomas like paratesticular sarcomas [2, 3]. Furthermore, the rarity of primary
fibrosarcoma in the testis further justifies the following report.
2. Case Report
A 21-year-old male, presented to the urology department with painless right testicular
swelling that increased in size insidiously within three months. No fever and no urinary
symptoms were reported. Left scrotum was free. On examination, about 10 cm right
testicular swelling was found—hard, not tender and oval in shape. Scrotal skin and
another testis were normal. Testicular ultrasound showed right heterogenous testic-
ular mass. Tumor markers like HCG and alpha fetoprotein were normal. CT chest and
abdomen were normal. Radical orchidectomy was done through inguinal approach,
and the spermatic cord was chopped at the internal inguinal ring.
Histopathology revealed fibrosarcoma of the testis, themicroscopic appearancewas
malignant hypercellular sacromatous tumor composed of long fascicle of fusiform
spindle-shaped cells arranged in herringbone pattern. Tumors have spindle-shaped
nuclei and the tumor cells are separated by interwoven collagen fibers arranged in
parallel fashion. There was mild to moderate anaplasia with scattered mitotic activity,
Figures 1–6, evident by immunohistochemistry (SMA, S100, Desmin were negative and
Ki67was positive in 10%denoting low proliferation index). After onemonth, he noticed
swelling in the same side of previous surgery, which was painless and increased in
size. Testicular ultrasound showed right testicular tumor and right inguinal lymph node
enlargement.
Right inguinal exploration with massive resection of the recurrent scrotal mass was
done. Histopathology revealed inflammatory process dominated by stitch granuloma.
3. Discussion
Sarcomas of the testis are extremely rare. When you review the literature of pub-
lished series of sarcomas they were distributed as follows: leiomyosarcoma (32%),
rhabdomyosarcoma (RMS, 24%) and liposarcoma (20%) are the commonest subtypes
[4, 5].
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Figure 1: Malignant hypercellular sacromatous tumor formedwith long fascicle of fusiform spindle-shaped
cells arranged in herringbone pattern—spindle-shaped nuclei with scanty cytoplasm and indistinct borders
(orange arrows)—Hematoxylin-eosin stain; magnification x 40 (A), magnification x 100 (B). The copyright
of the image is kept for the authors.
 
Figure 2: Collagen fibers arranged in parallel fashion : Hematoxylin-eosin stain; magnification x 10 (left)
and x 40 (right).
Figure 3: Ki67 immunochemistry is positive—in about 10% of tumor cells (magnification x 40).
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Figure 4: S100 is negative—immunochemistry (magnification x 40).
Figure 5: Desmin is negative—immunochemistry (magnification x 40).
Gowing and Morgan studied all mesenchymal tumors arising in testicular tissues,
and their relative rarity is apparent; the study consists of 22 sarcomas enrolled in a sur-
vey of around 1000 patients with testicular neoplasm. The majority of the sarcomas in
this study were mesenchymal, that is, fibrosarcoma, liposarcoma, myosarcoma, rhab-
domyosarcoma and leiomyosarcoma, or combinations [6]. The sarcomas may present
with a unilateral, painless scrotal swelling with short duration as seen in this case.
The commonest way of metastasis is via lymphatics to internal iliac and para-aortic
lymph nodes. Distant metastasis to liver, lungs and bone by hematogenous spread
accounts for 20% of patients in initial presentation [14]. Management of testicular
fibrosarcoma has shifted with multispecialty approaches that improves the survival
chances up to 80% by incorporating chemotherapeutic medications, radiotherapy or
surgical intervention [14, 15].
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In the current reported case, the radiological staging was N0M0, and accordingly the
oncologist preferred follow-up after radical orchidectomy. Inguinal approach orchidec-
tomy with ligation of spermatic cord at the internal ring is the standard surgical inter-
vention as seen in the case. The site of tumor origin (testicular-paratesticular), lymph
node involvement, distant metastasis, presence or absence of residual disease after
surgical resection will help in staging of testicular and the plan of management of
fibrosarcoma of the testis.
The reported local relapse rate in the scrotum and groin after orchidectomy is 25–
37% [8, 10, 11]. Adjuvant locoregional (ipsilateral pelvic and groin nodes and scrotum)
radiation and/or surgery apparently reduces rate of recurrence [7, 9, 11, 12]. Fagun-
des et al. [10] reported no local recurrence in patients receiving adjuvant radiation,
compared with 37% local recurrence in those managed with the removal of the testis
alone.
Catton et al. [13] mentioned 14% local recurrence in patients who underwent wide
local excision and/or radiotherapy after original excision of the testicular or parates-
ticular sarcomas. They also suggested that orchidectomy alone is inadequate for tes-
ticular sarcomas and recommended adjuvant wide hemiscrotum excision, which may
include inguinal lymph nodes for those managed with orchidectomy or local excision.
They found that therewasmicroscopic disease present in 27%, followingwide excision
in patients with apparently completely excised tumors.
In the current case, there was an appearance of swelling in the right testicle within
one month following radical orchidectomy, which made us to think of local recurrence,
and therefore the decision of re-exploration was made with wide local excision of the
swelling and the hemiscrotum. The patient was followed-up for six months and there
was no local recurrence or distant metastasis.
The role of retroperitoneal lymph node dissection (RPLND) in testicular sarcomas
remains controversial [5, 10, 16, 17]. Catton et al. [10] recommended RPLND in their
earlier series of 21 patients, but in their subsequent report they noted that the patients
with a high risk of nodal metastasis are also at highest risk of concurrent or subse-
quent systemic disease; accordingly, they felt that those patients would benefit from
systemic rather than regional treatment [13]. Others suggest that RPLND should be
limited to patients with suspicion of LN metastasis in the image [19]. In this case, we
advocate that the last suggestions is to do RPLND when there is radiological suspicion
of LN residual after adjuvant chemotherapy.
DOI 10.18502/sjms.v13i2.2638 Page 82
Sudan Journal of Medical Sciences Sami Mahjoub Taha et al
Adjuvant chemotherapy in testicular sarcomas is not fully established. In pediatrics,
with testicular sarcomas—especially rhabdomyosarcoma (RMS)—adjuvant chemother-
apy had good outcome on the overall survival [20, 21]. Its use in adult testicular sar-
comas has not been yet specifically addressed in a controlled study [22].
The use of post-intervention chemotherapy for adult high-grade testicular fibrosar-
coma is controversial. A meta-analysis of randomized trials of testicular sarcomas at
different centers showed that doxorubicin-based adjuvant chemotherapy significantly
improved the time to local and distant failure [23].
In conclusion, testicular fibrosarcoma is extremely rare testicular tumor. Although
recurrence rate is high following radical orchidectomy, but there was still a place of
non-malignant mass that looks like recurrence that might occur like a nonspecific
inflammatory mass and stich granuloma.
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